Bharat Biotech’s COVID 19 Vaccine Covaxin (Covaxin) has been criticized by many for DCGI’s approval of emergency use. Commentaries are being made about its safety, effectiveness and transparency on data. Reacting to these criticisms, Krishna Biyala, chairman and managing director (MD) of Bharat Biotech, has said that cocaine is 200 percent safe, we have good experience in making vaccines and we take science seriously. Indian companies are not entitled to such commentary comments.
Krishna Alla said in a press conference via video conferencing that the COVID 19 vaccine has shown less than 10 percent adverse effects, while 60–70 percent of the side effects of other vaccines have been reported. AstraZeneca was giving 4g paracetamol to volunteers to overcome them. We have not given paracetamol to any volunteer. I can assure that covaxine is 200 percent safe.
Covaxine is a simple two dose vaccine. Now, those who are more than 12 years old can be given such vaccine only. We are planning its trials on children soon. We will launch the vaccine as soon as possible. A consignment of vaccine has been sent to Kasauli Government Testing Lab.